Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
---|---|---|---|---|---|---|---|---|
Jul 16, 2025 | Jul 18, 2025 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $52.95 | $529,467 | -9.85% |
Jun 18, 2025 | Jun 21, 2025 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $54.84 | $89,554 | -1.77% |
Jun 16, 2025 | Jun 20, 2025 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $54.23 | $542,306 | -9.78% |
Jun 10, 2025 | Jun 12, 2025 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $54 | $151,351 | -2.95% |
May 15, 2025 | May 19, 2025 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $39.3 | $392,978 | -9.52% |
Apr 15, 2025 | Apr 16, 2025 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $37.91 | $343,962 | -8.72% |
Mar 17, 2025 | Mar 18, 2025 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $44.76 | $447,605 | -9.52% |
Mar 12, 2025 | Mar 15, 2025 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $44.88 | $27,556 | -0.64% |
Feb 18, 2025 | Feb 21, 2025 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $49.87 | $498,660 | -9.47% |
Jan 27, 2025 | Jan 31, 2025 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $56.25 | $3M | -35.91% |
Jan 27, 2025 | Jan 31, 2025 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $55.72 | $3M | -33.91% |
Dec 16, 2024 | Dec 19, 2024 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $29.11 | $264,117 | -8.66% |
Dec 10, 2024 | Dec 13, 2024 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $30.79 | $86,520 | -3.79% |
Nov 15, 2024 | Nov 20, 2024 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $27.73 | $251,274 | -10.89% |
Nov 06, 2024 | Nov 08, 2024 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $35.19 | $351,890 | -11.88% |
Oct 30, 2024 | Nov 02, 2024 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $32.6 | $651,960 | -21.24% |
Oct 15, 2024 | Oct 17, 2024 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $30.37 | $636,490 | -22.04% |
Sep 20, 2024 | Sep 23, 2024 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $27.65 | $152,086 | -6.81% |
Sep 16, 2024 | Sep 19, 2024 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $27.54 | $231,175 | -10.03% |
Sep 10, 2024 | Sep 13, 2024 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $26.18 | $16,677 | -0.84% |
Sep 03, 2024 | Sep 05, 2024 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $27.61 | $26,206 | -1.23% |
Aug 23, 2024 | Aug 28, 2024 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $27.52 | $386,714 | -15.62% |
Jun 11, 2024 | Jun 13, 2024 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $22.64 | $63,961 | -3.64% |
Mar 13, 2024 | Mar 15, 2024 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $28.33 | $20,483 | -0.92% |
Mar 04, 2024 | Mar 07, 2024 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $35.49 | $732,727 | -20.84% |
Dec 14, 2023 | Dec 19, 2023 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $20.76 | $12,394 | -0.76% |
Sep 13, 2023 | Sep 26, 2023 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $48.32 | $271,416 | -10.88% |
Aug 28, 2023 | Aug 30, 2023 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $49.99 | $287,191 | -10.97% |
Jun 21, 2023 | Jun 24, 2023 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $51.74 | $2M | -41.70% |
Jun 13, 2023 | Jun 16, 2023 | Yale Catriona Chief Development Officer | Sell | Akero Therapeutics, Inc. | AKRO | $55.16 | $32,600 | -0.73% |